MCEF, the newest member of the AF4 family of transcription factors involved in leukemia, is a positive transcription elongation factor-b-associated protein

Journal of Biomedical Science

Volumn 9, Issue 3, 2002, Pages 234-245

  Estable, Mario Clemente ^c,d   Naghavi, Mojgan H ^b   Kato, Hiroyuki ^d   Xiao, Hua ^d   Qin, Jun ^a   Vahlne, Anders ^b   Roeder, Robert G ^d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c RYERSON UNIVERSITY   (Canada)

^d ROCKEFELLER UNIVERSITY   (United States)

Author keywords

CDK9; HIV; Leukemia; Positive transcription elongation factor b; Transcription

Indexed keywords

ANTISERUM; CELL CYCLE PROTEIN; CELL CYCLE PROTEIN 37; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE 9; CYCLIN T1; EPITOPE; HEAT SHOCK PROTEIN 90; ISOPROTEIN; PROTEIN; PROTEIN P TEFB; RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AF4; TRANSCRIPTION FACTOR MCEF; UNCLASSIFIED DRUG; AFF4 PROTEIN, HUMAN; CDK9 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE; DSIF PROTEIN, HUMAN; HYBRID PROTEIN; NUCLEAR PROTEIN; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; PROTEIN SERINE THREONINE KINASE; REPRESSOR PROTEIN; SUPT4H1 PROTEIN, HUMAN;

ACUTE LYMPHOBLASTIC LEUKEMIA; AMINO ACID SEQUENCE; ARTICLE; CELL LINE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOPRECIPITATION; MOLECULAR CLONING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PURIFICATION; TRANSCRIPTION INITIATION; VIRUS REPLICATION; ENHANCER REGION; GENETICS; HELA CELL; LEUKEMIA; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; REPORTER GENE; SEQUENCE ALIGNMENT; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; CLONING, MOLECULAR; CYCLIN-DEPENDENT KINASES; ENHANCER ELEMENTS (GENETICS); GENES, REPORTER; HELA CELLS; HIV-1; HUMAN; LEUKEMIA; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT FUSION PROTEINS; SEQUENCE ALIGNMENT; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TISSUE DISTRIBUTION; TRANSCRIPTION FACTORS; CYCLIN-DEPENDENT KINASE 9; HUMANS; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; REPRESSOR PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036017215     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1159/000059424     Document Type: Article

References (45)

1. Hsp90 & Co. - A holding for folding
2. Tat activates human immunodeficiency virus type 1 transcriptional elongation independent of TFIIH kinase
3. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
4. Naturally occurring human immunodeficiency virus type 1 long terminal repeats have a frequently observed duplication that binds RBF-2 and represses transcription
5. Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity
6. Purification of RBF-2, a transcription factor with specificity for the most conserved cis-element of naturally occurring HIV-1 LTRs
7. Distinct clustering of HIV type 1 sequences derived from injection versus noninjection drug users in Vancouver, Canada
8. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA
9. Gene structure and subcellular localization of FMR2, a member of a new family of putative transcription activators
10. PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro
11. Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase
12. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: Candidate for a Tat cofactor
13. Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation
14. Domains in the SPT5 protein that modulate its transcriptional regulatory properties
15. Taking a new TAK on tat transactivation
16. Tackling Tat
17. Positive transcription elongation factor B phosphorylates hSPT5 and RNA polymerase II carboxyl-terminal domain independently of cyclin-dependent kinase-activating kinase
18. Initiation of translation in prokaryotes and eukaryotes
19. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro
20. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase
21. Control of formation of two distinct classes of RNA polymerase II elongation complexes
22. Purification of P-TEFb, a transcription factor required for the transition into productive elongation
23. Upstream stimulating factor affects human immunodeficiency virus type 1 (HIV-1) long terminal repeat-directed transcription in a cell-specific manner, independently of the HIV-1 subtype and the core-negative regulatory element
24. Long terminal repeat promoter/enhancer activity of different subtypes of HIV type 1
25. Transcriptional activity of positive transcription elongation factor b kinase in vivo requires the C-terminal domain of RNA polymerase II
26. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription
27. A novel RNA polymerase II-containing complex potentiates Tat-enhanced HIV-1 transcription
28. Identification of a cyclin subunit required for the function of Drosophila P-TEFb
29. Identification of multiple cyclin subunits of human P-TEFb
30. Tat-associated kinase (P-TEFb): A component of transcription preinitiation and elongation complexes
31. Domains with transcriptional regulatory activity within the ALL1 and AF4 proteins involved in acute leukemia
32. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II
33. An RNA polymerase II elongation factor encoded by the human ELL gene
34. AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23)
35. DSIF a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt 4 and Spt5 homologs
36. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA
37. TIP30 has an intrinsic kinase activity required for up-regulation of a subset of apoptotic genes
38. NELF a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation
39. Interplay between positive and negative elongation factors: Drawing a new view of DRB
40. Structure and function of the human transcription elongation factor DSIF
41. TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines
42. The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function
43. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription
44. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages
45. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro